Disclaimer :

The Competition DG makes the information provided by the notifying parties in section 1.2 of Form CO available to the public in order to increase transparency. This information has been prepared by the notifying parties under their sole responsibility, and its content in no way prejudges the view the Commission may take of the planned operation. Nor can the Commission be held responsible for any incorrect or misleading information contained therein.

SECTION 1.2

Description of the concentration

On 2 June 20022, the European Commission has received the notification of a proposed concentration pursuant to Article 4 of the EU Merger Regulation, concerning the indirect acquisition by Groupe Bruxelles Lambert SA of a majority controlling stake in Affidea Group B.V. (“Affidea”) by way of an indirect purchase of shares.

By virtue of this notified concentration, Groupe Bruxelles Lambert SA will acquire indirect, sole control over Affidea within the meaning of Article 3(1)(b) of the EU Merger Regulation.

Groupe Bruxelles Lambert SA, headquartered in Belgium, is a listed public investment holding company limited by shares (société anonyme / naamloze vennootschap) and invests in global companies operating in various sectors. Specifically, GBL holds a controlling interest in (i) Imerys S.A., active in in the production and processing of industrial minerals, (ii) Webhelp S.A.S, active in the provision of IT services (iii) ECP III, an investment fund of Ergon Capital Partners, (iv) Canyon Bicycles GmbH, active in the manufacture and direct-to-customer distribution of premium bikes and (v) the Etoile Properties Partners JV BV, a European real estate investment manager, advising foreign investors throughout their investment cycle from acquisition to disposal. GBL is jointly controlled by Ségolène Gallienne - Stichting A.K. Peupleraie (owned by Ségolène Gallienne, a private individual) and the Power Corporation of Canada group (ultimately owned by the Desmarais family).

Affidea, headquartered in the Netherlands, is a European diagnostic imaging company, with 320 centres operating across 15 countries, with its most sizable operations in Italy, Portugal, Poland and Romania. Affidea is active across the full diagnostic imaging value chain, providing an integrated pathway in advanced diagnostics, outpatient and cancer care services.

Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË

Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.